Cargando…

Efficacy and safety of immune checkpoint blockade for brain metastases

Detalles Bibliográficos
Autores principales: Harary, Maya, Reardon, David A, Iorgulescu, J Bryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713022/
https://www.ncbi.nlm.nih.gov/pubmed/30854898
http://dx.doi.org/10.2217/cns-2018-0018
_version_ 1783446798694612992
author Harary, Maya
Reardon, David A
Iorgulescu, J Bryan
author_facet Harary, Maya
Reardon, David A
Iorgulescu, J Bryan
author_sort Harary, Maya
collection PubMed
description
format Online
Article
Text
id pubmed-6713022
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-67130222019-08-29 Efficacy and safety of immune checkpoint blockade for brain metastases Harary, Maya Reardon, David A Iorgulescu, J Bryan CNS Oncol Commentary Future Medicine Ltd 2019-03-11 /pmc/articles/PMC6713022/ /pubmed/30854898 http://dx.doi.org/10.2217/cns-2018-0018 Text en © 2019 J Bryan Iorgulescu This work is licensed under a Creative Commons Attribution 4.0 License (http://creativecommons.org/licenses/by/4.0/)
spellingShingle Commentary
Harary, Maya
Reardon, David A
Iorgulescu, J Bryan
Efficacy and safety of immune checkpoint blockade for brain metastases
title Efficacy and safety of immune checkpoint blockade for brain metastases
title_full Efficacy and safety of immune checkpoint blockade for brain metastases
title_fullStr Efficacy and safety of immune checkpoint blockade for brain metastases
title_full_unstemmed Efficacy and safety of immune checkpoint blockade for brain metastases
title_short Efficacy and safety of immune checkpoint blockade for brain metastases
title_sort efficacy and safety of immune checkpoint blockade for brain metastases
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713022/
https://www.ncbi.nlm.nih.gov/pubmed/30854898
http://dx.doi.org/10.2217/cns-2018-0018
work_keys_str_mv AT hararymaya efficacyandsafetyofimmunecheckpointblockadeforbrainmetastases
AT reardondavida efficacyandsafetyofimmunecheckpointblockadeforbrainmetastases
AT iorgulescujbryan efficacyandsafetyofimmunecheckpointblockadeforbrainmetastases